Alliance Global Partners Starts Reviva Pharmaceuticals (RVPH) at Buy
Tweet
Share
E-mailGet Alerts RVPH Hot Sheet
Price: $0.35 --0%
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Alliance Global Partners analyst James Malloy initiates coverage on Reviva Pharmaceuticals (NASDAQ: RVPH) with a Buy rating.
For an analyst ratings summary and ratings history on Reviva Pharmaceuticals click here. For more ratings news on Reviva Pharmaceuticals click here.
Shares of Reviva Pharmaceuticals closed at $3.92 yesterday.
You May Also Be Interested In
- Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Oppenheimer Starts Carriage Services (CSV) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
